Experiment 442356
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | CHANG,AY: KIM,K: GLICK,J: ANDERSON,T: KARP,D: JOHNSON,D:. (1993). PHASE II STUDY OF TAXOL, MERBARONE, AND PIROXANTRONE IN STAGE IV NON-SMALL-CELL LUNG CANCER: THE EASTERN GROUP RESULTS.. 85(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | 24 PATIENTS WITH NON-SMALL CELL LUNG CANCER RECEIVED TAXOL IN THIS PHASE 2 STUDY. PATIENTS RECEIVED 1 COURSE EVERY THREE DAYS VIA IV INFUSION. 5 OF 24 PATIENTS SHOWED PARTIAL RESPONSE TO TREATMENT. THE MOST COMMON TOXICITY WAS LEUKOPENIA. THERE WAS 1 DEATH DIRECTLY RELATED TO TAXOL TREATMENT. OTHER TOXICITIES INCLUDED ANEMIA, DIARRHEA, CARDIAC TOXICITES AND NEUROLOGIC TOXICITIES. |
| Dose amount | 250.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |